NYMC Faculty Publications
A Review of onabotulinumtoxinA (Botox)
Author Type(s)
Faculty
DOI
10.1177/1090820X12474629
Journal Title
Aesthetic Surgery Journal
First Page
9
Last Page
9
Document Type
Article
Publication Date
3-1-2013
Department
Otolaryngology
Abstract
OnabotulinumtoxinA was introduced to the US market in 2002 as the first botulinum toxin type A (BoNTA) approved for facial aesthetics. This article provides an overview of onabotulinumtoxinA's uses and indications as well as safety and efficacy data. As with other BoNTA products, onabotulinumtoxinA is generally well tolerated. Consideration is also given to clinical applications of the product. Information on handling, storage, and dosing is provided.
Recommended Citation
Lorenc, Z., Kenkel, J., Fagien, S., Hirmand, H., Nestor, M., Sclafani, A., Sykes, J., & Waldorf, H. (2013). A Review of onabotulinumtoxinA (Botox). Aesthetic Surgery Journal, 33 (1 Suppl), 9-9. https://doi.org/10.1177/1090820X12474629
